Publication | Closed Access

Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway

Acute Lung InjuryInflammationAnti-inflammatoryInflammatory Lung DiseaseLung InflammationImmunologyPathologyPulmonary PharmacologyPulmonary FibrosisVascular BiologyMedicineNf-κb Signaling PathwayOxidative Stress